A Lansing company has received government approval to test a new anthrax vaccine on humans.
BioPort, which is the nation's only anthrax vaccine supplier, has already conducted tests on humans.
But the Lansing-based company asked the US Food and Drug Administration if it could test the vaccine with an added immune-stimulating molecule.
The molecule could potentially reduce the number of doses necessary.
BioPort's research will be funded by the US Department of Defense.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.